Words for clinical notes
Search 5,131 terms by clinical wording, everyday description, or note example.
| Word | Plain-English search cue | Original note example | SOAP section | Writing task |
|---|---|---|---|---|
| fibrin breakdown product measured by assay | The D-dimer is reported using the laboratory's stated units. | Objective | Hematology, coagulation and transfusion observations | |
dilute Russell viper venom time | venom-based clotting assay used in lupus anticoagulant testing | Dilute Russell viper venom time was reported with screening and confirmation results. | Objective | Coagulation, antibodies and hemostasis studies |
equivocal serology | antibody or antigen result falls into the assay's indeterminate zone | Equivocal serology was recorded with the assay-specific cutoff information. | Objective | Molecular testing, serology and culture findings |
factor IX activity | functional activity of factor nine in a coagulation assay | Factor IX activity was measured before the documented replacement dose. | Objective | Coagulation, antibodies and hemostasis studies |
factor VIII activity | functional activity of factor eight in a coagulation assay | Factor VIII activity was reported with the specimen collection time. | Objective | Coagulation, antibodies and hemostasis studies |
fecal occult blood | blood detected by a stool assay without visible bleeding | The laboratory reports a positive fecal occult blood test. | Objective | Hepatobiliary, pancreatic and nutrition findings |
galactomannan index | assay index measuring a fungal cell-wall antigen in the submitted specimen | The galactomannan index was documented with the assay and specimen source. | Objective | Molecular testing, serology and culture findings |
hydroxyitraconazole | active itraconazole metabolite measured in some drug assays | The laboratory lists hydroxyitraconazole separately on the antifungal drug report. | Objective | Drug levels - named analytes and exposure reports |
inoculum | amount of organism introduced into an assay or culture | The laboratory comment notes a low inoculum. | Objective | Microbiology and specimen interpretation |
invalid molecular result | assay could not generate an interpretable answer for the submitted sample | The invalid molecular result was reported with the laboratory's reason. | Objective | Molecular testing, serology and culture findings |
laboratory consultation | discussion with the laboratory about a result or assay | Request laboratory consultation about the discrepancy between assay methods. | Plan | Drug levels - verification and documentation |
levetiracetam | antiseizure medicine measurable in serum or plasma under an appropriate assay | The levetiracetam concentration was collected at a documented interval after the dose. | Objective | Drug levels - named analytes and exposure reports |
measured concentration | value obtained directly by assay | The measured concentration is recorded separately from the modeled estimate. | Objective | Drug levels - analyte, specimen and reporting |
minimum bactericidal concentration | lowest concentration meeting the assay's defined bacterial killing endpoint | The minimum bactericidal concentration was listed separately from the minimum inhibitory concentration. | Objective | Molecular testing, serology and culture findings |
plasma renin activity | measure of angiotensin I generation under specified assay conditions | Plasma renin activity was identified separately from a direct renin concentration. | Objective | Glucose monitoring, endocrine testing and urine studies |
target detected | assay identified the specific sequence or analyte being tested for | The report states "target detected" for one target on the respiratory panel. | Objective | Molecular testing, serology and culture findings |
target not detected | specified assay target was not identified in the submitted sample | The result states "target not detected" for the named target in this specimen. | Objective | Molecular testing, serology and culture findings |
thyroglobulin antibody | antibody to thyroglobulin that can affect interpretation of some thyroglobulin assays | The thyroglobulin antibody was measured with the thyroglobulin result. | Objective | Glucose monitoring, endocrine testing and urine studies |
undetectable | below the assay's detection threshold | Viral RNA undetectable by the reported assay. | Objective | Laboratory, imaging and test descriptors |
upper-limit exceedance | reported value exceeds the assay's quantitative upper boundary | Upper-limit exceedance was documented with the original greater-than sign. | Assessment | Medication response, exposure and reconciliation |
urinary antigen test | assay for a specified microbial antigen in urine | The urinary antigen test was documented with the organism targeted by the assay. | Objective | Molecular testing, serology and culture findings |
zonisamide | antiseizure medicine measurable by a drug-specific assay | The zonisamide specimen followed the dose change documented in the log. | Objective | Drug levels - named analytes and exposure reports |
absolute bioavailability | systemic availability relative to an intravenous reference with dose adjustment | The study estimated absolute bioavailability using paired oral and intravenous data. | Assessment | Drug concentrations, exposure and assay interpretation |
absorption lag time | delay between dosing and the start of measurable absorption in a model | The model includes an absorption lag time before concentrations begin to rise. | Assessment | Drug concentrations, exposure and assay interpretation |
absorption rate constant | parameter describing the rate of absorption in a specified model | The fitted absorption rate constant was reported with its units and model assumptions. | Assessment | Drug concentrations, exposure and assay interpretation |